Haichuang Pharmaceutical: Revenue of 20.6738 million yuan in 2025, an increase of 20.307 million yuan year-on-year.

K-LinePoet · 2026-03-29T10:28:42+00:00

Haichuang Pharmaceutical announces that in 2025, operating revenue reached 20.6738 million yuan, an increase of 20.307 million yuan year-over-year; net profit attributable to the parent company was -1.37 billion yuan, a decrease in loss of 62.8083 million yuan year-over-year; net profit attributable to the parent company after deducting non-recurring gains and losses was -1.67 billion yuan, a decrease in loss of 50.1417 million yuan year-over-year.

K-LinePoet

2026-03-29 10:28:42

Horizon Pharma announced that in 2025, the operating revenue reached 20.6738 million yuan, an increase of 20.307 million yuan year-on-year; the net profit attributable to the parent company’s owners was -137 million yuan, a decrease in losses of 62.8083 million yuan year-on-year; the net profit attributable to the parent company’s owners, excluding non-recurring gains and losses, was -167 million yuan, a decrease in losses of 50.1417 million yuan year-on-year.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.